I hope this company finally reaches a point of 'activation energy', brought on by wider news reach, brought on by undeniable value.
I also must provide the same disclaimer I have in the past, that is I am not a medical doctor, nor do I hold a doctoral degree in a specific subject. My alias relates to the Asimov creator of psychohistory, a mathematical model of human populations. Everything I ever write is just thoughts on my head at the moment and only one man's opinion.
My personal work did include research in a variety of areas that included the design and operation of scientific experiments. I enjoy researching a range of issues in a variety of the sciences. I find many recent medical advances fascinating. I think ISCO technology is real and meaningful. But it could still be usurped by something even newer and greater at almost any point. Many technologies are advancing in ways that they are complimenting each other and leading to wider applications, sprouting others. Even ones that influence the cellular level.
I am really glad of three things about ISCO. One is they seek products that alleviate suffering. The second is they have an operational business side that appears to be stable and slowly growing. That generates both revenue and experience in the mechanics and logistics of a functional producing business (i.e. - not scientific development). The third is they made it to Phase I Human Studies for intracranial transplantation of stem cell derived neural cells and the results are both good and encouraging. That is a major achievement I believe they are not being properly recognized for.
They look to be reaching a Phase II level in the near future. Many in the biotech industry will say new start companies are not even looked at until they are in Phase II. I will bet you even when they reach Phase II they will be under low recognition. It just seems to be that way for them. But some time into Phase II, especially if the operating units continue to expand and provide income, recognition will have to come. One would think....! But it is a strange world. Especially these days. The thing that has always impressed my about ISCO is that they seem to eventually do most of what they say they are going to. The thing that has bothered me the most is how low their cash reserves always ran. The chief insiders always kept it going by diluting, but putting their money in to do it. That seems to be doing the needed thing with confidence. It was nice to see the half million dollar investment purchase of new shares the other day. That added shares, but was not really dilutive since it went for $1.75, which was greater than open market share values. Still not too much dilution in this particular part of the company's phase. I still estimate real effective outstanding shares at somewhere around 30 million shares. If that stayed the same and the operating units continue to grow and expand, and Phase II gets going sooner than later, and Phase II shows good results, I see no reason why the company would not be worth at least 500 million market cap. That is $16.67 per share. That is a lot of ifs and whens. But this looks like at least some kind of positive from here. But, Ya never know. It is all my guess, done with a broken crystal ball by a guy who don't know shit from Shinola.........
Take care.....
Wishing all the best of good buys!
HS
News 
Market Data 
Discover 
